The Ministry of Agriculture of Spain has published, in its Foreign News gazette, that the National Food Health and Quality Service of Argentina (SENASA) has, through Resolution no. 1119/2018, forbidden the use of medicated feed that may contain benzimidazoles, imidazothiazoles, tetrahydropirimidines, cestodicidals and/or trematocidals as of year 2022.
The feeds that contain these active ingredients will remain included in their corresponding register until January 1st, 2022, but will be rejected as of January 2nd 2022.
The applications for the registration of feeds that contain the aforementioned drugs will be accepted until July 1st, 2020.
The Resolution makes clear that the feeds that contain monensin, sodium monensin, naransin, salinomycin, semduramicin, maduramicin, lasalocid, robenidine, nicarbazin and/or decoquinate are not included in the scope of the Resolution, so they are not affected by any restriction.
On the other hand, Resolution 22/2019 has forbidden the production, distribution, import, use and possession in all the country of veterinary products that contain colistin and its salts. The prohibition will come into force 180 days after the publishing of the Resolution (last January 16th).
Colistin has been considered a 'reserve' drug by the World Health Organisation (WHO) due to its importance for human health as an effective therapeutic tool for the treatment of infections caused by multidrug resistant bacteria in humans.
Also, the results obtained by the SENASA's National Program for the Surveillance of Resistances Against Antimicrobials in livestock showed significant levels of resistance against colistin, so colistin and its salts mustn't be administered to animals, with the aim of preserving their efficacy in humans.
Thursday, January 24th, 2019/ MAPA/ Spain.